BDBM516550 (2S)-1-[(2R)-2-(diethylamino)-2- phenylacetyl]-N-(4-{5-[({(2S)-1- [(2R)-2-(diethylamino)-2- phenylacetyl]pyrrolidin-2- yl}carbonyl)amino]-1H-indol-2- yl}phenyl)pyrrolidine-2- carboxamide::US11053243, Example 62

SMILES CCN(CC)[C@@H](C(=O)N1CCC[C@H]1C(=O)Nc1ccc(-c2cc3cc(NC(=O)[C@@H]4CCCN4C(=O)[C@@H](c4ccccc4)N(CC)CC)ccc3[nH]2)cc1)c1ccccc1

InChI Key InChIKey=UKJNYHDKMYFUSH-UHFFFAOYSA-N

Data  1 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 516550   

TargetGenome polyprotein(HCV)
Merck Sharp & Dohme

US Patent
LigandChemical structure of BindingDB Monomer ID 516550BDBM516550(US11053243, Example 62 | (2S)-1-[(2R)-2-(diethylam...)
Affinity DataEC50:  0.0670nMAssay Description:Measurement of inhibition by compounds was performed using the HCV replicon system. Several different replicons encoding different HCV genotypes or m...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/13/2022
Entry Details
US Patent